Research Reports
Sigachi Laboratories Ltd Unlisted Shares
Sigachi Laboratories Ltd Share Price
PHYSICAL
PRIVATE LIMITED
Price Chart
1W
1M
1Y
MAX
High
₹58
Low
₹12
Return
-12.73%
Sigachi Laboratories Ltd Essentials
As of April 22, 2026, Sigachi Laboratories Ltd, Unlisted Shares are trading at ₹48.00 per share and face value is ₹10.00/share, with a 52-week high of ₹48.00 and 52-week low of ₹43.00. The minimun lot size is 5000 shares, and the shares are traded on NSDL and CDSL.
ISIN
INE368H01018
An International Securities Identification Number (ISIN) is a code that uniquely identifies a specific securities issue. The numbers are allocated by a country's respective national numbering agency (NNA).
Face Value
10
Value of a security, as stated by its issuer. It has no relation with market price of the stock.
Total Shares
67,53,100
Total shares or total number of shares outstanding represents the amount of stock on the open market, including shares held by institutional investors and restricted shares held by insiders and company officers.
Market Cap
32.41 Cr
Market capitalization is the aggregate valuation of the company based on its current share price and the total number of outstanding shares.
Profit After Tax
1.99 Cr
It is the final profit left over after subtracting all operating and non operating items from net revenue.
Total Revenue
1.34 Cr
Gross income refers to the total income earned by an individual on a pay check before taxes and other deductions. It comprises all incomes received by an individual from all sources – including wages, rental income, interest income, and dividends.
P/E
16.3
It is a valuation parameter that measures the company's current share price relative to its per-share earnings. Generally, high P/E is Overvalued & low P/E is Undervalued.
P/B
1.07
It shows the relationship between the current price and the book value of each share. A lower P/B ratio can mean that the stock is undervalued.
Sector
Health Care
A sector is an area in which businesses share the same or a related product or service. It can also be known as an industry or market that shares common operating characteristics
Sub-sector
Pharmaceuticals
Subsectors are the divisions of a sector. They are areas that vary from the rest of the sector substantially enough to justify creating a plan just for the subsector.
Category
Listed on Small Exchange
Category is defined as a class or division of things regarded as having particular shared characteristics.
Cashflow - Operations
-1.9 Cr
It indicates the amount of money a company brings in from its ongoing and regular operations over a fixed period of time.
About Sigachi Laboratories Ltd
- Sigachi Laboratories Limited operates as a pharmaceutical company. The company focuses on the business of manufacturing bulk drugs and drug intermediates. Apart from manufacturing drugs, the company is also involved in investing and mostly invests in equity and mutual funds with its primary focus on pharmaceuticals, banking, and energy sectors.
- Sigachi Laboratories has leased out its two factories since 1st, November 2017 and thus the company is dependent on lease rental from only one party.
- The company manufactures pharmaceutical products - Bulk drugs and drug intermediates. The company is undertaking contract manufacturing, job works for the manufacture of bulk drugs and drug intermediates.
- The company's shares have been listed at Metropolitan Stock Exchange of India Limited and the latest trading price is ₹15 per share.
- Sigachi Laboratories Limited is a public company incorporated on 21st November 1994, with its registered office at SY.NO.530 & 534, Temple Road, Bonthapally Village, Jinnaram Mandal, Medak Dist., TG 000000 IN.
Want to See a Detailed Investment Analysis?
Explore in-depth financial analysis, performance metrics, and key disclosures.
Sigachi Laboratories Ltd Media
News
Articles
Videos
Sigachi Industries establishes state-of-the-art R&D Center in Hyderabad
03 Feb 2025
• Business Standard
Sigachi Laboratories standalone net profit rises 140.54% in the December 2023 quarter
15 Feb 2024
• Business Standard
Sigachi Laboratories standalone net profit rises 36.67% in the September 2021 quarter
02 Nov 2021
• Business Standard
Frequently Asked Question (FAQs)
Where can I find the annual report of Sigachi Laboratories Ltd Ltd?
The annual report of Sigachi Laboratories Ltd Ltd is available in the annual report section.
How to buy Sigachi Laboratories Ltd Unlisted Shares?
Please find below the procedure for buying Sigachi Laboratories Ltd Unlisted Shares at Planify.
• 1. You confirm booking of Sigachi Laboratories Ltd Unlisted Shares with us at a trading price.
• 2. You provide your client master report (ask the broker if not available) along with PAN Card and Cancelled Cheque in case you are not transferring funds from the bank account as mentioned in the CMR Copy. These are KYC documents required as per SEBI regulations.
• 3. We will provide the bank details.
• 4. You need to transfer funds in that account.
• 5. Payment has to be done in RTGS/NEFT/IMPS CHEQUE TRANSFER. No CASH DEPOSIT.
• 6. Payment has to be done from the same account in which shares are to be credited.
• 7. We will transfer the shares in 24 hours if funds are credited before 2 pm.
Important Note: Please note that the lock-in period for selling Sigachi Laboratories Ltd Unlisted Shares is 6 months after listing. Hence you can’t sell Sigachi Laboratories Ltd Unlisted Shares which you bought in Pre-IPO for 6 months after its listing. i.e. You can sell it only after 6 months calculated from the listing date.
What is the lock-in period of Sigachi Laboratories Ltd Unlisted Shares?
Lock-in period of Sigachi Laboratories Ltd Unlisted Shares depends upon category of investors.
• 1. Venture Capital Funds or Alternate Investment Fund of Category -I or II, or Foreign Venture Capital Investor - lock-in Period of 6 months from the date of acquisition of Sigachi Laboratories Ltd Unlisted Shares.
• 2. Other Investors (include Retail, HNIs or Body Corporate) lock-in Period of 6 months from the date of listing of IPO of Sigachi Laboratories Ltd Unlisted Shares.
This new SEBI rule was introduced in the month of August-2021, wherein the SEBI has reduced the lock-in period previously from 1 year to 6 months to encourage more and more funds to be invested in startups which are going to public or IPO in near future. Reduction of lock-in is seen as big step and after that many PMS funds are advising their clients to invest in Pre-IPO shares to get the benefit of early stage investment.
See More
Sigachi Laboratories Ltd
₹ 48
